Lipocalin: A Novel Diagnostic Marker for Hepatocellular Carcinoma in Chronic Liver Disease Patients in Egypt - International Journal of Clinical Medicine

IJCM > Vol.4 No.10, October 2013

International Journal of Clinical Medicine

Volume 4, Issue 10 (October 2013)

ISSN Print: 2158-284X ISSN Online: 2158-2882

Google-based Impact Factor: 0.52 Citations h5-index & Ranking

Lipocalin: A Novel Diagnostic Marker for Hepatocellular Carcinoma in Chronic Liver Disease Patients in Egypt ()

HTML

Download as PDF (Size: 507KB) PP. 440-450

DOI: 10.4236/ijcm.2013.410079 3,050 Downloads 4,624 Views Citations

Author(s)

Hoda Aly Abd El Moety, Rania Mahamed El Sharkawy, Nevin Abd El Menem Hussein

Affiliation(s)

Chemical Pathology, Medical Research Institute, Alexandria University, Alexandria, Egypt.
Chemical Pathology, Medical Research Institute, Alexandria University, Alexandria, Egypt;.
Chemistry, Medical Research Institute, Alexandria University, Alexandria, Egypt..

ABSTRACT

Hepatocellular carcinoma is one of the most prevalent life-threatening human cancers with etiological factors chronic viral hepatitis B and C infections. Tumor cell dispersion relies on the loss of homotypic cell-cell adhesion. Invasion through basement membrane and interstitial extracellular matrix is another key event for metastatic progression, which requires the action of a series of proteolytic enzymes named matrix metalloproteinases, secreted by tumor cells that enhance tumor invasiveness and metastasis. TIMPs are dominant inhibitors of MMPs and able to control MMP-mediated ECM breakdown by binding active forms of MMPs. Lipocalin-2 is known as neutrophil gelatinase associated lipocalin promotematrix degradation and tumor progression. Aim: To evaluate the importance of lipocalin for diagnosis HCC in Egyptian chronic liver disease patients. Subjects and Methods: 50 patients and 25 controls. (G-1) 25 HCC on top of hepatitis C. (G-2) 25 hepatitis C. The following done: schistosoma antibodies, ASAM, LKM-1, ANA AKA and CBC. Hepatitis B surface antigen, Hepatitis C antibodies AFP, Cupper and zinc, Matrix metaloprotinase-9, TIMP-1 and Neutrophil gelatinase-associated lipocalin. Results: Median value of MMP-9 level in G-I (206 μg/L) is significantly higher than G-2 (100 μg/L) and G 3 (49 μg/L) p < 0.001. TIMP-9 median value G-1 (48 μg/L) is significantly lower than G-2 (54 μg/L) and G-3 (113 μg/L) p < 0.001. Lipocalin-2 median levels are significantly higher in G-I (389 ng/mL) than G-2 (166 ng/ml) versus G-3 (60 ng/mL) p < 0.001. Lipocalin-2 associated with increasing lobular inflammation, ballooning & fibrosis with MMP-9 has an important role in pathogenesis of liver cirrhosis and HCC. Conclusion: We elucidated predictive value for MMPs, TIMPs, and progression metastasis of hepatocellular carcinoma. Liver cell impairment alters metabolism of trace metals as zinc and copper, with possible relationship of these changes to pathogenesis of chronic liver disease. Lipocalin-2 can be used as a future diagnostic marker with better sensitivity and specificity than MMP-9 for the progression of hepatocelluar carcinoma.

KEYWORDS

Lipocalin-2; MMP-9; TIMP-1; Cu; Zn; HCC

Share and Cite:

H. Moety, R. Sharkawy and N. Hussein, "Lipocalin: A Novel Diagnostic Marker for Hepatocellular Carcinoma in Chronic Liver Disease Patients in Egypt," International Journal of Clinical Medicine, Vol. 4 No. 10, 2013, pp. 440-450. doi: 10.4236/ijcm.2013.410079.

Cited by

[1]	A Scoping Review on Lipocalin-2 and Its Role in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma
	2021

[2]	Lipocalin-2: A novel diagnostic marker for hepatocellular carcinoma
	2020

[3]	Urine Neutrophil Gelatinase-Associated Lipocalin a Possible Diagnostic Marker for Egyptian Hepatocellular Carcinoma Patients
	2020

[4]	Study of Oncoprotein 24p3 as Diagnostic Marker for Hepatocellular Carcinoma on Top of Hepatitis C Virus.
	2019

[5]	Study of Oncoprotein 24p3 as Diagnostic Marker for Hepatocellular Carcinoma on Top of Hepatitis C Virus
	2019

[6]	Lipocalin 2 as A Potential Diagnostic and/or Prognostic Biomarker in Prostate, Lung and Liver Cancer
	2018

[7]	Improving Anti-Cancer Potentiality and Bioavailability of Gallic Acid by Designing Polymeric Nanocomposite Formulation
	2018

[8]	Altered mitochondrial and peroxisomal integrity in lipocalin-2-deficient mice with hepatic steatosis
	Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2017

[9]	Exploiting bilosomes for delivering bioactive polysaccharide isolated from Enteromorpha intestinalis for hacking hepatocellular carcinoma
	Identity, 2017

[10]	Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy
	Frontiers in physiology, 2016

[11]	Lipocalin 2 in the pathogenesis of fatty liver disease and nonalcoholic steatohepatitis
	Clinical Lipidology, 2015

[12]	Serological tumor markers of hepatocellular carcinoma: a meta-analysis
	The International journal of biological markers, 2015

[13]	Oxidative Role of Aflatoxin B1 on the Liver of Wheat Milling Workers. OA Maced J Med Sci. 2014 Mar 15; 2 (1): 141-146
	2014

[14]	Oxidative Role of Aflatoxin B1 on the Liver of Wheat Milling Workers
	Macedonian Journal of Medical Sciences, 2014

Journals Menu

Follow SCIRP

	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journals Menu

Home

About SCIRP

Service

Policies